21 November 2017
News and Views
Links and Services
Regular use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer, reports this week's issue of the New England Journal of Medicine.
Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clin
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors